Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells.

about

Synergistic antitumor activity of low-dose c-Met tyrosine kinase inhibitor and sorafenib on human non-small cell lung cancer cells.

Item

http://www.wikidata.org/entity/Q52649739

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Synergistic antitumor activity ...... -small cell lung cancer cells.

@en

Synergistic antitumor activity ...... -small cell lung cancer cells.

@nl

type

Item

label

Synergistic antitumor activity ...... -small cell lung cancer cells.

@en

Synergistic antitumor activity ...... -small cell lung cancer cells.

@nl

prefLabel

Synergistic antitumor activity ...... -small cell lung cancer cells.

@en

Synergistic antitumor activity ...... -small cell lung cancer cells.

@nl

P1476

Synergistic antitumor activity ...... -small cell lung cancer cells.

@en

P2093

Hongxue Cui

http://www.w3.org/2001/XMLSchema#string

Liang Guo

http://www.w3.org/2001/XMLSchema#string

Ling Fu

http://www.w3.org/2001/XMLSchema#string

Mingyue Zhang

http://www.w3.org/2001/XMLSchema#string

Xiaohua Zhao

http://www.w3.org/2001/XMLSchema#string

Yi Zheng

http://www.w3.org/2001/XMLSchema#string

Zhenyu Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signaling.

Global cancer statistics, 2012

Cancer statistics, 2010

Mechanism of c-MET in Non-small Cell Lung Cancer and Its Treatment and Testing

Epidermal growth factor receptor mutations in lung cancer

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

Efficacy of sorafenib in advanced renal cell carcinoma independent of prior treatment, histology or prognostic group.

New knowledge of the mechanisms of sorafenib resistance in liver cancer

CAF-derived HGF promotes cell proliferation and drug resistance by up-regulating the c-Met/PI3K/Akt and GRP78 signalling in ovarian cancer cells.

AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenografts.

P304

5081-5086

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2018.7933

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-02-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29552141

http://www.w3.org/2001/XMLSchema#string

P932

5840610

http://www.w3.org/2001/XMLSchema#string